7
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Demonstration of Intermediate Filament Proteins in the Guinea Pig Vestibular Labyrinth by a New, High-resolution Cryotechnique

, , &
Pages 377-380 | Published online: 08 Jul 2009
 

Abstract

In order to establish the more precise localization of IFPs in the vestibular labyrinth we have developed an immunohis-tochemical method using semithin cryosections from guinea pig inner ear. The vestibular end organs were fixed by intralabyrinthine perfusion with formaldehyde and glutaraldehyde. Microdissection was performed, followed by decalcifi-cation in EDTA. After specimen embedding in gelatin, semithin cryosections (1 μm) were prepared. Prior to the immunohistochemical staining, a new antigen-unmdsking treatment was performed. Monoclonal antibodies for cytoker-atins (Cks), vimentin, neurofilament protein (NF), and glial fibrillary acidic protein (GFAP) were used and visualized with an indirect ABC method. In the guinea pig vestibular labyrinth, Cks8, 18 and 19 were present. Virnentin and NF were stained positively, GFAP negatively. These results are in accordance with our previous results in the human vestibular labyrinth except for Ck7. The high-resolution cryotechnique in combination with a new antigen-unmasking method may yield more, and more detailed information about the localization of IFPs in the vestibular region.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.